Research information, not medical advice. This page summarises published evidence and registered trials so that you can look further; it does not assess your situation. Talk to your own clinician before acting on anything here. How we select and grade sources
Based on: Endometriosis — gene targets, candidate compounds and trials, OSMF Research Tracker (DGIdb, Open Targets, ChEMBL, PubMed and ClinicalTrials.gov data). Numbers are a snapshot taken 28 October 2026; the tracker page is the live version.
Full trial data → The Endometriosis pipeline page on the Research Tracker has every candidate, gene target and trial, with evidence grades.
Short answer: as of October 2026, the OSMF Research Tracker lists 40 candidate medicines for endometriosis that are either approved medicines or have at least one registered clinical trial, built on 11 druggable gene targets, with 15 recent trials on ClinicalTrials.gov. 1 are already approved medicines, for this condition or another one; where the approval is for a different condition, the trial is testing a new use, which is what drug repurposing means. Being in a trial says an intervention is being studied, not that it works; that is what the trial is for.
Which candidates have the most trial activity?
Ranked by the number of registered trials the tracker found. Each trial ID links to the registry entry, where you can read the design, status and sponsor.
- Elagolix — 9 registered trials · in clinical trials · NCT01403038
- GnRH-analogue — 2 registered trials · in clinical trials · NCT02091557 NCT02086279
- Letrozole — 2 registered trials · in clinical trials · NCT05487092 NCT00240942
- linzagolix (OBE2109) — 1 registered trial · approved medicine · NCT02778399
- A non-invasive blood-based (HerResolve) — 1 registered trial · in clinical trials · NCT07006987
- Alcohol sclerotherapy — 1 registered trial · in clinical trials · NCT02669628
- Argon Beam Coagulator — 1 registered trial · in clinical trials · NCT06414083
- BAY1817080 - Formulation A — 1 registered trial · in clinical trials · NCT03773068
- BAY1817080 - Formulation B — 1 registered trial · in clinical trials · NCT03773068
- BAY2328065 LSF — 1 registered trial · in clinical trials · NCT04027192
- BAY2328065 tablet — 1 registered trial · in clinical trials · NCT04027192
- Circulating DNA analysis — 1 registered trial · in clinical trials · NCT07471373
Which gene targets are these built on?
The tracker starts from genes with evidence of being druggable in endometriosis and asks which compounds act on them. Each symbol links to its DGIdb entry, which lists the interacting drugs and the papers behind them: CYP19A1, ESR1, ESR2, GNRHR, HSD17B1, IL6, NGF, PGR, PTGS2, TNF, VEGFA.
Which trials are registered?
Drug and biologic treatment trials whose main condition is endometriosis, from the tracker's ClinicalTrials.gov snapshot. Full trial data →
- Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis NCT07755956 · Recruiting · Phase 1 · started 2026-10-31
- Comparison Between the Effects of Implantable Gestrinone and Oral Dienogest in the Treatment of Endometriosis NCT06543550 · Recruiting · Phase 4 · started 2024-07-30
- A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis NCT07260669 · Active Not Recruiting · Phase 2 · started 2025-10-15
- Cardiovascular Disease Risk in Women With Endometriosis NCT03746535 · Completed · Phase Early 1 · started 2022-07-01
- Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis NCT06477406 · Active Not Recruiting · Phase 2 · started 2024-02-27
- Anti-TNFα Therapy for Improving Pregnancy Rates in Endometriosis Patients With Failed ICSI NCT07509411 · Completed · Phase 2 · started 2025-08-15
- Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain NCT07318688 · Recruiting · Phase 3 · started 2026-01-29
- Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain NCT07728695 · Recruiting · Phase 1/2 · started 2026-09
- Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis NCT07696351 · Recruiting · Phase 4 · started 2025-08-01
- The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial NCT06439524 · Recruiting · Phase 3 · started 2024-08-15
- Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain NCT04333576 · Active Not Recruiting · Phase 3 · started 2020-08-10
- Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment NCT05570786 · Completed · Phase 2 · started 2023-02-13
- A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain NCT05560646 · Completed · Phase 2 · started 2022-10-25
- A Clinical Study of KLH-2109 in Patients With Endometriosis NCT07015268 · Active Not Recruiting · Phase 3 · started 2025-06-09
- Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain NCT07100782 · Recruiting · Phase 3 · started 2025-12-08
How to read this
Evidence is graded on the tracker page in three tiers: clinical (tested in people), mechanistic (a documented action on the target) and correlative (an association in the literature). Most candidates sit in the lower tiers, and many trials are small or early-phase. The list is restricted to medicines and supplements: trial arms that are devices, procedures, behavioural programmes or measurements are filtered out automatically, so an occasional misclassified entry is possible; the tracker page lists every arm. The purpose of this list is to show where the research is, with sources, so that patients, clinicians and researchers can look further; it is not a ranking of what to take. How sources are chosen, graded and corrected is set out in our editorial policy.
More Chronic Disease notes
Related on this site
Research information, not medical advice. Decisions about any medicine belong with you and your clinician. The underlying data are open (CC BY 4.0) and refreshed daily; this note was generated from the tracker page on 28 October 2026.